{
    "clinical_study": {
        "@rank": "112688", 
        "arm_group": [
            {
                "arm_group_label": "study group", 
                "arm_group_type": "Experimental", 
                "description": "the patients that will get a nitrate patch"
            }, 
            {
                "arm_group_label": "control group", 
                "arm_group_type": "Placebo Comparator", 
                "description": "the patients that will get the placebo patch"
            }
        ], 
        "brief_summary": {
            "textblock": "The pathogenesis of AVN includes a defective blood supply to the knee joint. Local nitrates\n      induce peripheral vasodilation and may improve blood supply to the affected tissue.\n\n      This study aims to test whether the use of a nicotine patch may accelerate the healing\n      process from AVN of the knee."
        }, 
        "brief_title": "Nitrate Patch Use as Treatment of Knee AVN", 
        "completion_date": {
            "#text": "January 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Necrosis, Avascular, of Bone", 
        "condition_browse": {
            "mesh_term": [
                "Necrosis", 
                "Osteonecrosis"
            ]
        }, 
        "detailed_description": {
            "textblock": "The main purpose of this study is to examine whether treatment with a local nitrate patch\n      will improve MRI findings and clinical outcomes in patients with AVN of the knee.\n\n      This is a double-blind prospective study that will include 50 adult volunteers, randomly\n      assigned to a \"nitrate\" group that will be given a nitrate patch, and a \"placebo\" group that\n      will be given a placebo patch.\n\n      The following outcomes will be measured:\n\n        -  MRI findings before and after the patch treatment\n\n        -  Use of analgesics\n\n        -  Subjective pain relief."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  adult patients (18-80 y.o)\n\n          -  diagnosis of AVN according to MRI\n\n        Exclusion Criteria:\n\n          -  Terminal illness\n\n          -  Cognitive impairment / any condition disturbing informed concent.\n\n          -  Nitrate intolerance\n\n          -  Patients using Cyclic GMP inhibitiors"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "50", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 3, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01979666", 
            "org_study_id": "SHEBA-12-9707-AL-CTIL"
        }, 
        "intervention": [
            {
                "arm_group_label": "study group", 
                "description": "patients in the study group will get a nitrate patch", 
                "intervention_name": "nitrate patch", 
                "intervention_type": "Drug", 
                "other_name": "nitrate patch"
            }, 
            {
                "arm_group_label": "control group", 
                "description": "control group patients will get a placebo patch", 
                "intervention_name": "placebo patch", 
                "intervention_type": "Drug", 
                "other_name": "placebo"
            }, 
            {
                "arm_group_label": [
                    "study group", 
                    "control group"
                ], 
                "description": "MRI scan after 6 weeks of treatment", 
                "intervention_name": "MRI scan", 
                "intervention_type": "Device", 
                "other_name": "MRI"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": "Knee AVN, Nitrates", 
        "lastchanged_date": "January 21, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Ramat Gan", 
                    "country": "Israel"
                }, 
                "name": "Sheba Medical Center"
            }
        }, 
        "location_countries": {
            "country": "Israel"
        }, 
        "number_of_arms": "2", 
        "official_title": "the Effect of a Nitrate Patch on the Healing Process of AVN of the Knee", 
        "overall_contact": {
            "email": "avi.livneh@sheba.health.gov.il", 
            "last_name": "Avi Livneh, MD", 
            "phone": "972-3-530-2454"
        }, 
        "overall_contact_backup": {
            "email": "arik.asman@sheba.health.gov.il", 
            "last_name": "Arik Asman, MD", 
            "phone": "972-3-530-2454"
        }, 
        "overall_official": [
            {
                "affiliation": "Sheba Medical Center", 
                "last_name": "avi livneh", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Sheba Medical Center", 
                "last_name": "arik asman, MD", 
                "role": "Study Director"
            }
        ], 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Israel: Ministry of Health", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "January 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "the area and percent of the knee which the edema involves", 
            "measure": "Reduction in bone substrate edema", 
            "safety_issue": "No", 
            "time_frame": "6 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01979666"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Sheba Medical Center", 
            "investigator_full_name": "Prof.Avi Livneh", 
            "investigator_title": "head of internal medicine ward F", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "reduction of subchondral fracture resolution of accompanied findings presence of femoral head or condyle flattening", 
                "measure": "other MRI changes", 
                "safety_issue": "No", 
                "time_frame": "6 weeks"
            }, 
            {
                "description": "according to the patient's self report", 
                "measure": "analgesics use", 
                "safety_issue": "No", 
                "time_frame": "6 weeks"
            }, 
            {
                "description": "according to a visual analouge scale", 
                "measure": "pain severity", 
                "safety_issue": "No", 
                "time_frame": "6 weeks"
            }
        ], 
        "source": "Sheba Medical Center", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Sheba Medical Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}